Try our Advanced Search for more refined results

Expert Analysis

Examining Sequenom Prenatal Testing Patent Litigation

Law360, New York (July 18, 2012, 1:05 PM EDT) -- On July 5, Judge Susan Ilston of the U.S. district court in San Francisco issued a decision denying a motion by Sequenom for a preliminary injunction barring a private company called Ariosa Diagnostics from marketing its noninvasive prenatal test to determine pertinent facts about an unborn fetus, such as whether the fetus has Down syndrome (trisomy 21), Edwards syndrome (trisomy 18) or Patau syndrome (trisomy 13)....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Government Agencies

Patents

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!